Dr. Richard Whitlock and Dr. C. Michael Gibson Discuss: The Left Atrial Appendage Occlusion Study (LAAOS) III May 15, 2021 Disclosures: TBD
Dr. Schuyler Jones, Mr. Greg Merritt, and Dr. C. Michael Gibson Discuss: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial May 15, 2021 Disclosures: TBD
Dr. Eugene Braunwald and Dr. C. Michael Gibson Discuss: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (paradise-mi) May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss How to Initiate Heart Failure Drugs February 16, 2021 Disclosures: TBA
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss Shockwave FDA Approval February 16, 2021 Disclosures: TBA
Dr. Pierre Amarenco Presents: Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Tia of Atherosclerotic Origin February 10, 2021 Disclosures: TBA
Dr. Alexandra J Lansky Presents: A Prospective Multicenter Randomized Controlled Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System in Patients With Stable or Non-ST Elevation Acute Coronary Syndromes: Primary Endpoint Results of the PIONEER III Trial February 10, 2021 Disclosures: TBA
Heart Success: Dr. Carolyn Lam and Dr. C. Michael Gibson Talk About Success in the Battle Against Heart Failure November 20, 2020 Disclosures: TBA
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial November 17, 2020 Disclosures: TBA
